1. Home
  2. CMTL vs FLNA Comparison

CMTL vs FLNA Comparison

Compare CMTL & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

N/A

Current Price

$1.34

Market Cap

52.7M

Sector

Technology

ML Signal

N/A

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.96

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMTL
FLNA
Founded
1967
1998
Country
United States
United States
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
61.8M
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
CMTL
FLNA
Price
$1.34
$0.96
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$4.25
★ $6.50
AVG Volume (30 Days)
238.5K
★ 4.5M
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $499,528,000.00
$41,119,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.36
$0.67
52 Week High
$6.21
$2.03

Technical Indicators

Market Signals
Indicator
CMTL
FLNA
Relative Strength Index (RSI) 27.70 59.45
Support Level N/A $0.85
Resistance Level $1.57 $1.02
Average True Range (ATR) 0.05 0.10
MACD -0.00 0.03
Stochastic Oscillator 2.27 50.98

Price Performance

Historical Comparison
CMTL
FLNA

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: